“Glitazones”, a prospect for non-insulin-dependent diabetes

This publication has 8 references indexed in Scilit:

• The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
• Appraisal of effectiveness and potential therapeutic benefit of acarbose: A non-consensus conference
  Diabetologia, 1996
• Effect of Combination Therapy of Troglitazone and Sulphonylureas in Patients with Type 2 Diabetes Who Were Poorly Controlled by Sulphonylurea Therapy Alone
  Diabetic Medicine, 1996
• Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
  Journal of Clinical Investigation, 1995
• Measurement of Proinsulin and Intermediates: Validation of Immunoassay Methods by High-Performance Liquid Chromatography
  Diabetes, 1995
• Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
  New England Journal of Medicine, 1994
• New Pharmacological Approaches to Insulin and Lipid Metabolism
  Drugs, 1994
• Pathogenesis of NIDDM: A Balanced Overview
  Diabetes Care, 1992